Volume 16, Issue 3 pp. 257-262

Complications of Percutaneous Treatment of Thrombosed Hemodialysis Access Grafts

Stephen Ash

Stephen Ash

Section Editor

University of Pennsylvania School of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author
Francis L. Weng

Francis L. Weng

University of Pennsylvania School of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author
Jeffrey S. Berns

Jeffrey S. Berns

University of Pennsylvania School of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Search for more papers by this author
First published: 09 October 2008
Citations: 23
Address correspondence to: Jeffrey S. Berns, MD, University of Pennsylvania School of Medicine, Renal, Electrolyte, and Hypertension Division, Presbyterian Medical Center, 240 Medical Office Building, 51 N. 39th St., Philadelphia, PA 19104, or e-mail: [email protected].

Abstract

ABSTRACT Percutaneous catheter-based thrombolysis is commonly used in association with angioplasty to treat thrombosed hemodialysis arteriovenous grafts. Although major complications of these percutaneous procedures are relatively uncommon, they can result in several potentially serious complications, including pulmonary embolism, cerebral embolism, arterial embolism, bleeding with perigraft hematoma or hemorrhage, and vein rupture. This article reviews the epidemiology, clinical significance, and management of these complications.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.